Do Your Genes Put You at a Higher Risk of Developing Mesothelioma



Status:Completed
Conditions:Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:11/9/2017
Start Date:June 2011
End Date:December 2015

Use our guide to learn which trials are right for you!

Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma

The purpose of this research study is to investigate the possibility that a person's genes
put a person at a higher risk of developing mesothelioma. The investigators will examine
genes from DNA (genetic material) isolated from blood. This study will also examine the
impact of environmental and work exposures and family history of common cancers on the
development of mesothelioma. The genetic markers in this study will basically identify how a
person's body processes frequently encountered environmental pollutants and will not tell
about chromosomes, specific diseases, or other potential health problems.

Mesothelioma is a cancer that develops from serosal surfaces usually in response to prior
asbestos exposure. A history of asbestos exposure can be elicited in more than 80% of
mesothelioma victims. However, asbestos exposure alone is not sufficient to cause the
development of mesothelioma. Nearly 27 million individuals in the US, were exposed to
asbestos in the work place between 1940 and 1979 but just 3,000 new cases of mesothelioma are
diagnosed each year. Therefore, the investigators hypothesis is that genetic variation in
addition to asbestos exposure, and host factors contribute to the development of
mesothelioma. It is estimated, based on the investigators preliminary studies, that a
population in excess of 1,000 subjects with mesothelioma is required to perform a valid GWAS.

Therefore a multicenter approach is necessary to collect data and DNA on sufficient numbers
with mesothelioma to adequately evaluate genetic risk. It is the aim of this proposal to
develop a consortium of mesothelioma investigators to share phenotypic data and DNA samples
and to perform genome wide association scanning (GWAS).

Inclusion Criteria:

- Subjects able to provide informed consent who suffer from mesothelioma

Exclusion Criteria:

- Inability to provide informed consent

- Absence of mesothelioma in self
We found this trial at
6
sites
3400 N Charles St
Baltimore, Maryland 21205
410-516-8000
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
550 1st Ave
New York, New York 10016
(212) 263-7300
New York University School of Medicine NYU School of Medicine has a proud history that...
?
mi
from
New York, NY
Click here to add this to my saved trials
1275 York Ave
New York, New York 10021
(212) 639-2000
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials
3451 Walnut St
Philadelphia, Pennsylvania 19104
1 (215) 898-5000
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
1 Medical Center Blvd
Winston-Salem, North Carolina 27157
336-716-2011
Wake Forest University Health Sciences Welcome to Wake Forest Baptist Medical Center, a fully integrated...
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials